Kenvue Is Currently Recruiting For a
Sr. Scientist –R&D Analytical Self Care (FIXED TERM 12 MONTHS)
What We Do
At Kenvue, we realize the extraordinary power of everyday care. Built on over a century of heritage and rooted in science, we're the house of iconic brands - including NEUTROGENA, AVEENO, TYLENOL, LISTERINE, JOHNSON'S and BAND-AID that you already know and love. Science is our passion; care is our talent.
Who We Are
Our global team is ~ 22,000 brilliant people with a workplace culture where every voice matters, and every contribution is appreciated. We are passionate about insights, innovation and committed to delivering the best products to our customers. With expertise and empathy, being a Kenvuer means having the power to impact millions of people every day. We put people first, care fiercely, earn trust with science and solve with courage – and have brilliant opportunities waiting for you Join us in shaping our future–and yours. For more information, click here.
Role Reports To
CIENTISTA ESP
Location:
Latin America, Brazil, Sao Paulo, Sao Jose dos Campos
Work Location:
Hybrid
What You Will Do
The R&D Analytical Scientist is responsible for deliver the analytical projects for Self-Care portfolio (Drug Products and Drug Substances) supporting Latin America in local and regional scope. Solid experience in development/validation; postgraduate education is desirable.
This individual will independently lead the execution of analytical activities related to test method development and validation. He/she will also write and review technical documents including analytical method assessments, method validation / transfer protocols, and reports applied statistics, and GMP. This individual also have the responsibility to transfer test methods to quality control laboratory and lead lab activities related to troubleshooting solving, lab investigations and material characterization, running analysis and independently operating equipment as HPLC/UPLC, GC-FID, among others.
Key Responsibilities
* Lead the execution of method development, validation and method transfer to the quality control laboratory, and also support its related activities (test method creation/revision, change controls, support investigations, etc.);
* Write and review technical documents including analytical method assessments, validation protocols and validation reports in accordance with standard operating procedures and regulatory requirements;
* Conduct developmental stability studies analysis with critical results evaluation;
* Represent the team in analytical technical discussion;
* Communicate clearly with the internal organization (Kenvue Self Care related areas – Regulatory, Product Development, Quality & Compliance, etc.);
* Collaborate effectively with project members following priorities, checkpoints, and timelines to support milestones;
* Communicate issues which require escalation;
* Sense of urgency is needed to actively respond to problems and opportunities.
What we are looking for
Required Qualifications
* Bachelor's degree in Pharmacy, Chemistry, Chemical Engineering, or related fields; postgraduate education in Analytical Development/Validation or Quality Assurance is a plus. (Aligned with ANVISA GMP requirements for qualified personnel);
* Proficiency in HPLC/UPLC, GC, USP dissolution systems, data integrity systems and LIMS/ELN.
* Validation and verification of analytical methods (HPLC/UPLC, GC, UV/Vis, IR) according to RDC 166/2017 (selectivity, linearity, range, accuracy, precision, LOD/LOQ, robustness, matrix effect; method transfer/revalidation). High expertise on method validation and method transfer execution;
* Stability studies (accelerated, long‑term, and follow‑up) according to RDC 318/2019.
* GMP compliance (PIC/S‑aligned): documentation, data integrity, CAPA, change control, audits, and method transfer.
* Use of official compendia, especially USP and Brazilian Pharmacopoeia.
* Ability to work independently and in a team environment;
* Intermedial level of English (oral and written communication).
Desired Qualifications
* Development and validation of dissolution methods for oral solid dosage forms, according to the Dissolution Guide – ANVISA Guide nº 14/2021 v2 (medium selection, apparatus, agitation, temperature, discriminative power, and acceptance criteria).
* Forced degradation studies and establishment of degradation profiles and mass balance, aligned with ICH Q1A(R2) and Brazilian requirements for degradation products.
* Impurity control and risk assessment, including:
* Elemental impurities per ICH Q3D(R2);
* Degradation products under the national regulatory framework (RDC 53/2015 and 2023 updates — RDC 821/2023 and IN 258/2023).
If you are an individual with a disability, please check our Disability Assistance page for information on how to request an accommodation.